Triple co-administration of ivermectin, albendazole and praziquantel in zanzibar: a safety study.

BACKGROUND: Public health interventions based on distribution of anthelminthic drugs against lymphatic filariasis (LF), onchocerciasis, soil-transmitted helminthiasis (STH) and schistosomiasis have been implemented separately to date. A better use of available resources might be facilitated by a mor...

Full description

Bibliographic Details
Main Authors: Khalfan A Mohammed, Hamad J Haji, Albis-Francesco Gabrielli, Likezo Mubila, Gautam Biswas, Lester Chitsulo, Mark H Bradley, Dirk Engels, Lorenzo Savioli, David H Molyneux
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2008-01-01
Series:PLoS Neglected Tropical Diseases
Online Access:http://europepmc.org/articles/PMC2217668?pdf=render
_version_ 1818338698960306176
author Khalfan A Mohammed
Hamad J Haji
Albis-Francesco Gabrielli
Likezo Mubila
Gautam Biswas
Lester Chitsulo
Mark H Bradley
Dirk Engels
Lorenzo Savioli
David H Molyneux
author_facet Khalfan A Mohammed
Hamad J Haji
Albis-Francesco Gabrielli
Likezo Mubila
Gautam Biswas
Lester Chitsulo
Mark H Bradley
Dirk Engels
Lorenzo Savioli
David H Molyneux
author_sort Khalfan A Mohammed
collection DOAJ
description BACKGROUND: Public health interventions based on distribution of anthelminthic drugs against lymphatic filariasis (LF), onchocerciasis, soil-transmitted helminthiasis (STH) and schistosomiasis have been implemented separately to date. A better use of available resources might be facilitated by a more coordinated approach to control such infections, including the possibility of co-administering the three recommended anthelminthic drugs through a single, large-scale intervention. METHODOLOGY/PRINCIPAL FINDINGS: Ivermectin, albendazole and praziquantel were co-administered to 5,055 children and adults living in areas endemic for LF, STH and schistosomiasis in Zanzibar, United Republic of Tanzania, during a pilot intervention aimed at elucidating and quantifying possible side-effects. Subsequently, these drugs were co-administered to about 700,000 individuals during a countrywide intervention targeting a large part of the total population of Zanzibar. Passive and active surveillance measures carried out during both interventions showed that side-effects attributable to the three drugs given at the same time were mild and self-limiting events. CONCLUSIONS/SIGNIFICANCE: Our data suggest that co-administration of ivermectin, albendazole and praziquantel is safe in areas where lymphatic filariasis, soil-transmitted helminthiasis and schistosomiasis are co-endemic and where several rounds of treatment with one or two drugs have been implemented in the past. Passive surveillance measures, however, should be continued and detection, management and reporting of possible side-effects should be considered a key component of any health intervention administering drugs.
first_indexed 2024-12-13T15:15:15Z
format Article
id doaj.art-43057ea73a3743be88c900e4c5245a7f
institution Directory Open Access Journal
issn 1935-2727
1935-2735
language English
last_indexed 2024-12-13T15:15:15Z
publishDate 2008-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS Neglected Tropical Diseases
spelling doaj.art-43057ea73a3743be88c900e4c5245a7f2022-12-21T23:40:43ZengPublic Library of Science (PLoS)PLoS Neglected Tropical Diseases1935-27271935-27352008-01-0121e17110.1371/journal.pntd.0000171Triple co-administration of ivermectin, albendazole and praziquantel in zanzibar: a safety study.Khalfan A MohammedHamad J HajiAlbis-Francesco GabrielliLikezo MubilaGautam BiswasLester ChitsuloMark H BradleyDirk EngelsLorenzo SavioliDavid H MolyneuxBACKGROUND: Public health interventions based on distribution of anthelminthic drugs against lymphatic filariasis (LF), onchocerciasis, soil-transmitted helminthiasis (STH) and schistosomiasis have been implemented separately to date. A better use of available resources might be facilitated by a more coordinated approach to control such infections, including the possibility of co-administering the three recommended anthelminthic drugs through a single, large-scale intervention. METHODOLOGY/PRINCIPAL FINDINGS: Ivermectin, albendazole and praziquantel were co-administered to 5,055 children and adults living in areas endemic for LF, STH and schistosomiasis in Zanzibar, United Republic of Tanzania, during a pilot intervention aimed at elucidating and quantifying possible side-effects. Subsequently, these drugs were co-administered to about 700,000 individuals during a countrywide intervention targeting a large part of the total population of Zanzibar. Passive and active surveillance measures carried out during both interventions showed that side-effects attributable to the three drugs given at the same time were mild and self-limiting events. CONCLUSIONS/SIGNIFICANCE: Our data suggest that co-administration of ivermectin, albendazole and praziquantel is safe in areas where lymphatic filariasis, soil-transmitted helminthiasis and schistosomiasis are co-endemic and where several rounds of treatment with one or two drugs have been implemented in the past. Passive surveillance measures, however, should be continued and detection, management and reporting of possible side-effects should be considered a key component of any health intervention administering drugs.http://europepmc.org/articles/PMC2217668?pdf=render
spellingShingle Khalfan A Mohammed
Hamad J Haji
Albis-Francesco Gabrielli
Likezo Mubila
Gautam Biswas
Lester Chitsulo
Mark H Bradley
Dirk Engels
Lorenzo Savioli
David H Molyneux
Triple co-administration of ivermectin, albendazole and praziquantel in zanzibar: a safety study.
PLoS Neglected Tropical Diseases
title Triple co-administration of ivermectin, albendazole and praziquantel in zanzibar: a safety study.
title_full Triple co-administration of ivermectin, albendazole and praziquantel in zanzibar: a safety study.
title_fullStr Triple co-administration of ivermectin, albendazole and praziquantel in zanzibar: a safety study.
title_full_unstemmed Triple co-administration of ivermectin, albendazole and praziquantel in zanzibar: a safety study.
title_short Triple co-administration of ivermectin, albendazole and praziquantel in zanzibar: a safety study.
title_sort triple co administration of ivermectin albendazole and praziquantel in zanzibar a safety study
url http://europepmc.org/articles/PMC2217668?pdf=render
work_keys_str_mv AT khalfanamohammed triplecoadministrationofivermectinalbendazoleandpraziquantelinzanzibarasafetystudy
AT hamadjhaji triplecoadministrationofivermectinalbendazoleandpraziquantelinzanzibarasafetystudy
AT albisfrancescogabrielli triplecoadministrationofivermectinalbendazoleandpraziquantelinzanzibarasafetystudy
AT likezomubila triplecoadministrationofivermectinalbendazoleandpraziquantelinzanzibarasafetystudy
AT gautambiswas triplecoadministrationofivermectinalbendazoleandpraziquantelinzanzibarasafetystudy
AT lesterchitsulo triplecoadministrationofivermectinalbendazoleandpraziquantelinzanzibarasafetystudy
AT markhbradley triplecoadministrationofivermectinalbendazoleandpraziquantelinzanzibarasafetystudy
AT dirkengels triplecoadministrationofivermectinalbendazoleandpraziquantelinzanzibarasafetystudy
AT lorenzosavioli triplecoadministrationofivermectinalbendazoleandpraziquantelinzanzibarasafetystudy
AT davidhmolyneux triplecoadministrationofivermectinalbendazoleandpraziquantelinzanzibarasafetystudy